Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Oncolytics Biotech Inc ONCY


Primary Symbol: T.ONC

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune... see more

TSX:ONC - Post Discussion

Oncolytics Biotech Inc > Another week almost over, recap
View:
Post by canadafan on Apr 26, 2024 1:49pm

Another week almost over, recap

Hello all;
Yet another week is almost over.
Acutually 3 more trading days & a new month.
Did anything important or significant happen this week?
Regarding my comments, I have extream myopia. Being an Onc chat board, I only see or care about Onc progress, developments and outlooks.
in that regard? How is Onc doing ? This week?
On the heals of announcing the FDA meeting request for phase 3 MBc details, they announced an upcoming presentation at ASCO, 
Date being May 23, before the abstract details we be public.
Two features, one being TIL expansion in pancreatic, Brest & colon cancer.
The other being a further update on Pancreatic cancer.
Not to be forgotten, they. Did announce goid reults from the colon leg of the gobblet trials.
I would not be surprised if they added the colon cancer to an additional phase 3 enrolment.
Shareholder value? Absolutely. 
Things need to happen. The science is slow. However many avenues point towards Onc being successful. 
They won't be showcasing bad outcomes at ASCO.
Safe weekend all.
Comment by Noteable on Apr 26, 2024 2:03pm
As soon as this airy fairy xanadoo thread went up, someone hit the bid and the stock went down - which only means that xanadoo's posts are front running his trades.
Comment by canadafan on Apr 26, 2024 10:12pm
notable, I appreciate your never ending posts if semi- relevant information. I get the connections etc. this is  the second or third time you try to equate my posts with trades? Respectfully thst is the silliest connection/ acusation I have ever heard. As I said previously, I post more or less every day. typically end of week to comment on events of the week, or perhaps Sunday leading ...more  
Comment by Lesalpes29 on Apr 27, 2024 11:19am
Ignore button is really good for unstable!
Comment by Buckhenry on Apr 27, 2024 12:52pm
Finally good to see folks figuring out unnoteable has been blowing smoke for years.guess it takes some folks longer than others. But I'm sure he will still have his cult following. 
Comment by Peladawn on Apr 27, 2024 1:11pm
Hey Buckyboy!.....Instead of your constant useless and childish criticism of Notable and his posts, why don't you go ahead and analyze one of them for us...................................................................................................yeah, lol.........I didn't think so!
Comment by Peladawn on Apr 27, 2024 1:15pm
What we've figured out, is that you're the single solitary bonehead that has been liking the equally useless and childish criticism coming from Lesalpes.
Comment by 13X2413 on Apr 27, 2024 1:28pm
That Senior Medical Writer position with Onc remains unfilled. Good old Note would be perfect. He/she could put his/her literary (cut and paste) skills to good use. Why waste good talent on pumping. 
Comment by Buckhenry on Apr 27, 2024 4:07pm
Wow a job doing control  C and V making six figures. ... who would have everyday thunked  that....
Comment by 13X2413 on Apr 26, 2024 3:41pm
There sure doesn't seem to be any pomp and pageantry over any upcoming news. 11,000 shares today is pitiful.  I love your positive vibes, but it's sure not a market wide feeling.  All I ask for is a minor miracle, is that too much to ask. Get this up to a price that starts with a 3. 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities